SK Capital Partners LP buys generic pharmaceutical company for an undisclosed amount. Read on
“We are excited to work with SK Capital, whose industry expertise and resources will help grow our leadership in the market,” Apotex chief executive Jeff Watson said in a statement Wednesday.Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc.By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails.
RBC Capital Markets, Bank of Nova Scotia, Jefferies LLC and Deutsche Bank Securities Inc. were the advisers for the deal.Canopy Growth to sell Tweed, Tokyo Smoke stores to OEGRC and Four20 owner